Cells expressing mNeonGreen alone. by Xinwen Zhu (14709669)

Architecture of cultured thymus, day 12. by Laura P. Hale (8616885)

“…Bar represents 1 mm in A and 500 μm in B–D.</p>…”

IL-17A promotes the expression of osteoclast-related genes involved in osteoclastogenesis. by Hao Tang (44155)

Maternal Smoking during Pregnancy and DNA-Methylation in Children at Age 5.5 Years: Epigenome-Wide-Analysis in the European Childhood Obesity Project (CHOP)-Study by Peter Rzehak (212019)

“…This study thus replicates previous findings in children ages 3 to 5, 7 and 17 and confirms the postnatal stability of <i>MYO1G</i>, <i>CNTNAP2</i> and <i>FRMD4A</i> differential methylation. …”

Table_5_In vitro Neuroprotective Potential and Lipidomics Study of Olive Leaves Extracts Enriched in Triterpenoids.XLSX by Rocío Gallego (9723148)

“…Moreover, several triacylglycerols were found decreased. These results suggest triterpenoids from olive leaves as good neuroprotective candidates, and open a new gate for future experiments using in vivo models to corroborate this hypothesis.…”

Linking gene of interest to hygromycin expression cassette lowers overall expression. by Xinwen Zhu (14709669)

Study Flow Diagram. by Elizabeth S. Munroe (21568166)

Photomicrographs of cerebellum from control and <i>Giardia</i> parasitized gerbils. by Angélica González Maciel (18946369)

Overall movement and disability scales in the patients with <i>DYT</i>-1 dystonia, PKAN, and tardive dystonia. by Hye Ran Park (844306)

<i>In vitro</i> properties of IP2.0. by Sayuri Hara-Kuge (4954180)

“…The raw data of Fig 2D is available in figshare (<a href="https://doi.org/10.6084/m9.figshare.5976067.v1" target="_blank">https://doi.org/10.6084/m9.figshare.5976067.v1</a>).…”

EP4 Antagonism Alters Macrophage, Collagen, and Mmp Expression After Repair. by Michael B. Geary (789146)

“…<b>5C</b>: EP4 antagonism resulted in significant decreases in type I collagen (<i>Col1a1</i>) expression at 10 days post-repair (black bars). …”

Percentage of violacein production in <i>Chromobacterium violaceum</i> by the most active synthesized 1,2,3,5-tetrazine derivatives (4a, 4b and 4c). by Jean Paul Dzoyem (6424445)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Order effects are milder for P2A compared to T2A. by Xinwen Zhu (14709669)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Tixagevimab/ Cilgavimab. by Elizabeth S. Munroe (21568166)

Antibody and antigen responses to nMAb vs placebo day 1–90 for Bamlanivimab. by Elizabeth S. Munroe (21568166)

Longitudinal antibody and antigen responses to treatment vs placebo day 1–90 for nMAbs, among patients alive and with day 90 antibody and antigen measures (Sensitivity Analysis). by Elizabeth S. Munroe (21568166)